Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK's combined MMRV vaccine in healthy children
NCT00127023Phase 3Completed
- Sponsor
- GSK
- Start
- May 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of GSK208136 in measles, mumps, rubella and 1 more (2 arms), sponsored by GSK. Primary endpoint: Antibody levels after vaccination. Started May 2005; status: completed.
02
Drugs
GSK208136
03
Conditions
measlesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT00127023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00127023.